Private health care market in Poland to be worth over $12 billion in 2013

17 July 2011

The value of the private health care segment in Poland increased by about 4% year-on-year in 2010, to 28.8 billion zlotys ($10,38 billion), and is expected to be worth 34.4 billion zlotys ($12.39 billion) in 2013, according to the latest report published by the Polish research and consulting company PMR.

This figure includes payments for medicines and medical equipment, rehabilitation services, diagnostic tests and visits to doctors paid out of patients’ pockets, informal payments, subscriptions offered by medical companies, private health insurance sold by insurance companies and other charges covered directly by patients.

Market to grow 6% on average

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical